11 – 20 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data
(
- Contribution to journal › Article
-
Mark
Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden
(
- Contribution to journal › Article
-
Mark
The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions.
(
- Contribution to journal › Article
- 2008
-
Mark
The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments
(
- Contribution to journal › Article
-
Mark
The burden of rheumatoid arthritis and access to treatment: determinants of access
(
- Contribution to journal › Article
-
Mark
The burden of rheumatoid arthritis and access to treatment: health burden and costs
(
- Contribution to journal › Article
-
Mark
Patient access to rheumatoid arthritis treatments
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
The burden of rheumatoid arthritis and access to treatment: uptake of new therapies
(
- Contribution to journal › Article
-
Mark
The costs of treating glaucoma with combinations of topical drugs in Spain
(
- Contribution to journal › Article
-
Mark
Disease status, costs and quality of life of patients with rheumatoid arthritis in France: The ECO-PR Study.
(
- Contribution to journal › Article